The aim of extracorporeal detoxification through plasma exchange therapy is to eliminate protein-bound components and to prevent their potential toxic effects. It is thought that hyperbilirubinemia has a direct cytotoxic effect on T lymphocytes and that it thus increases infection and sepsis. The use of bilirubin absorption column reduces bilirubin levels in patients with hepatic insufficiency. For the first time in Turkey, we presented a patient with cardiac cirrhosis and high bilirubin levels who was successfully treated with bilirubin absorption column method
Bilirubin is the end product of degradation of the heme moiety of hemoproteins. Hemoglobin, derived ...
Background/Aims: Many potentially toxic molecules accumulate in the blood during hepatic dysfunction...
The toxicity of high concentrations of bilirubin in the plasma has previously been demonstrated in v...
Bilirubin removal from blood and curing patients suffering from hyperbilirubinemia by surgery, medic...
Hyperbilirubinemia is a common clinical manifestation, and may be life threatening. Many diseases re...
Introduction: Hyperbilirubinemia may have deleterious effects on many organs, even after the neonata...
The incidence of hyperbilirubinemia is high clinically, which is difficult to cure by medication, su...
Hyperbilirubinemia, which causes jaundice, is quite common in newborns. Typically bilirubin is bound...
Hyperbilirubinemia often accompanies liver failure; therefore, artificial liver support devices are ...
Abstract Objective Hyperbilirubinemia after cardiac surgery increases in-hospital mortality and is a...
There are different methods of artificial liver support for patients with acute liver dysfunction (A...
Background: Hyperbilirubinemia caused severe hepatobiliary diseases with various causes, especially ...
PURPOSE: Limited options are available to treat critically ill patients with acute liver failure (AL...
CPFA is an extracorporeal treatment used in severe sepsis to remove circulating proinflammatory cyto...
The molecular adsorbent recycling system (MARS) is now widely used in the treatment of patients with...
Bilirubin is the end product of degradation of the heme moiety of hemoproteins. Hemoglobin, derived ...
Background/Aims: Many potentially toxic molecules accumulate in the blood during hepatic dysfunction...
The toxicity of high concentrations of bilirubin in the plasma has previously been demonstrated in v...
Bilirubin removal from blood and curing patients suffering from hyperbilirubinemia by surgery, medic...
Hyperbilirubinemia is a common clinical manifestation, and may be life threatening. Many diseases re...
Introduction: Hyperbilirubinemia may have deleterious effects on many organs, even after the neonata...
The incidence of hyperbilirubinemia is high clinically, which is difficult to cure by medication, su...
Hyperbilirubinemia, which causes jaundice, is quite common in newborns. Typically bilirubin is bound...
Hyperbilirubinemia often accompanies liver failure; therefore, artificial liver support devices are ...
Abstract Objective Hyperbilirubinemia after cardiac surgery increases in-hospital mortality and is a...
There are different methods of artificial liver support for patients with acute liver dysfunction (A...
Background: Hyperbilirubinemia caused severe hepatobiliary diseases with various causes, especially ...
PURPOSE: Limited options are available to treat critically ill patients with acute liver failure (AL...
CPFA is an extracorporeal treatment used in severe sepsis to remove circulating proinflammatory cyto...
The molecular adsorbent recycling system (MARS) is now widely used in the treatment of patients with...
Bilirubin is the end product of degradation of the heme moiety of hemoproteins. Hemoglobin, derived ...
Background/Aims: Many potentially toxic molecules accumulate in the blood during hepatic dysfunction...
The toxicity of high concentrations of bilirubin in the plasma has previously been demonstrated in v...